DSM-Firmenich AG

DSFIR: XAMS (NLD)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|XVLOCK|LYyLOCK|%>p>^w

DSM-Firmenich: Sales Growth Fueled by Customer Preorders but Outlook Confirmed; Shares Cheap

DSM-Firmenich reported 4% organic sales growth in the first quarter, driven entirely by volume across all segments. The company announced a dual listing on the SIX Swiss Exchange from May 21 and a EUR 540 million share buyback. Shares rose by about 7% on May 6.

Sponsor Center